aHUSUK had been a participating stakeholder in the review of the process for approving new medicines in Scotland called for by the Scottish Government ( a few days before eculizumab was evaluated by the SMC!). Previous aHUSUK reports on progress of the review can seen by clicking here and here. The Review was led by… Continue Reading